c="alpha 2 beta 2" 1:3 1:6||t="medication"||cui="C1589399"||tot="Beta-2"||ns="-861"
c="abnormal profile" 2:1 2:2||t="test"||cui="C1979963"||tot="Profile"||ns="-861"
c="new hemoglobin variant" 2:22 2:24||t="test"||cui="C0474542"||tot="Hemoglobin variant test"||ns="-901"
c="increased oxygen affinity" 2:49 2:51||t="problem"||cui="C0311408"||tot="Increased oxygen affinity"||ns="-1000"
c="heterozygous carrier" 2:83 2:84||t="problem"||cui="C0560175"||tot="Carrier of disorder"||ns="-861"
c="not erythremic" 2:86 2:87||t="problem"||cui="C0032463"||tot="Polycythemia Vera"||ns="-789"
